References
- Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262
- Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on inherited primary arrhythmia syndromes. Heart Rhythm. 2013 Dec;10(12):1932-1963. doi: 10.1016/j.hrthm.2013.05.014
- Ackerman MJ, Tester DJ, Driscoll DJ. Molecular autopsy of sudden unexplained death in the young. Am J Forensic Med Pathol. 2001 Jun;22(2):105-111. doi: 10.1097/00000433-200106000-00001
- Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: Europace. 2011 Aug;13(8):1077-1109. doi: 10.1093/europace/eur245
- Wilde AAM, Semsarian C, Márquez MF, et al. EHRA/HRS/APHRS/LAHRS expert consensus statement on the state of genetic testing for cardiac diseases. Europace. 2022 Sep 1;24(8):1307-1367. doi: 10.1093/europace/euac030
- Kany S, Chelu MG, Lubitz SA. Genetic testing in early-onset atrial fibrillation. Eur Heart J. 2024 Sep 7;45(34):3111-3123. doi: 10.1093/eurheartj/ehae298
- Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007 Jul 19;448(7151):353-357. doi: 10.1038/nature06007
- Ellinor PT, Lunetta KL, Albert CM, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012 Apr 29;44(6):670-675. doi: 10.1038/ng.2261
- Roselli C, Chaffin MD, Weng LC, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018 Jun 11;50(9):1225-1233. doi: 10.1038/s41588-018-0133-9
- Lubitz SA, Yin X, Lin H, et al. Genetic risk prediction of atrial fibrillation. Circulation. 2017 Apr 4;135(14):1311-1320. doi: 10.1161/CIRCULATIONAHA.116.024143
- Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993 Aug;88(2):782-784. doi: 10.1161/01.CIR.88.2.782
- Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003 May 8;348(19):1866-1874. doi: 10.1056/NEJMoa022147
- Moss AJ, Zareba W, Kaufman ES, et al. Increased risk of arrhythmic events associated with specific HERG mutations in long QT syndrome. Circulation. 2002 Feb 19;105(7):794-799. doi: 10.1161/hc0702.105124
- Moss AJ, Robinson J, Gessman L, et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with long QT syndrome. Am J Cardiol. 1999 Oct 15;84(8):876-879. doi: 10.1016/s0002-9149(99)00458-0
- Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference. Circulation. 2005 Feb 8;111(5):659-670. doi: 10.1161/01.CIR.0000152479.54298.51
- Hong K, Brugada J, Oliva A, et al. Value of electrocardiographic parameters and family history in risk stratification of Brugada syndrome. Circulation. 2004 Nov 9;110(19):3023-3027. doi: 10.1161/01.CIR.0000144299.17008.07
- Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998 Mar 19;392(6673):293-296. doi: 10.1038/32675
- Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE registry. J Am Coll Cardiol. 2012 Jan 3;59(1):37-45. doi: 10.1016/j.jacc.2011.08.064
- Sieira J, Ciconte G, Conte G, et al. Long-term prognosis of drug-induced Brugada syndrome. Heart Rhythm. 2017 Oct;14(10):1427-1433. doi: 10.1016/j.hrthm.2017.04.044
- Brugada R, Campuzano O, Sarquella-Brugada G, Brugada J, Brugada P. Brugada syndrome. Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):25-28. doi: 10.14797/mdcj-10-1-25
- Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation. Circulation. 2011 Mar 29;123(12):1270-1279. doi: 10.1161/CIRCULATIONAHA.110.972612
- Pappone C, Brugada J, Vicedomini G, et al. Electrical substrate elimination in in 135 consecutive patients with Brugada syndrome. Circ Arrhythm Electrophysiol. 2017 May;10(5):
e005053 . doi: 10.1161/CIRCEP.117.005053 - Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002 Jul 2;106(1):69-74. doi: 10.1161/01.CIR.0000020013.73106.D8
- Hayashi M, Denjoy I, Extramiana F, et al. The role of implantable cardioverter-defibrillators in catecholaminergic polymorphic ventricular tachycardia. Circulation. 2009 May 12;119(18):2426-2434. doi: 10.1161/CIRCULATIONAHA.108.829267
- van der Werf C, Kannankeril PJ, Sacher F, et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol. 2011 May 31;57(22):2244-2254. doi: 10.1016/j.jacc.2011.01.026
- Watanabe H, Chopra N, Laver D, et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med. 2009 Apr;15(4):380-383. doi: 10.1038/nm.1942
- Kallas D, Roberts JD, Sanatani S, Roston TM. Calcium Release Deficiency Syndrome: A New Inherited Arrhythmia Syndrome. Card Electrophysiol Clin. 2023 Sep;15(3):319-329. doi: 10.1016/j.ccep.2023.05.003
- Pattridge HK, Ponce-Balbuena D, Ríos Pérez EB, Eckhardt LL, Valdivia HH, Alvarado FJ. Loss-of-Function Mutation RyR2-A4860G Confers an Arrhythmia Phenotype in Mice Inconsistent With Calcium Release Deficiency Syndrome. Circ Arrhythm Electrophysiol. 2026 Jan;19(1):
e014337 . doi: 10.1161/CIRCEP.125.014337 - Przybylski R, Abrams DJ. Current management of inherited arrhythmia syndromes associated with the cardiac ryanodine receptor. Curr Opin Cardiol. 2023 Jul 1;38(4):390-395. doi: 10.1097/HCO.0000000000001051
- Gollob MH, Redpath CJ, Roberts JD. The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol. 2011 Feb 15;57(7):802-812. doi: 10.1016/j.jacc.2010.09.048
- Giustetto C, Di Monte F, Wolpert C, et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J. 2006 Oct;27(20):2440-2447. doi: 10.1093/eurheartj/ehl185
- Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to HERG mutations. Circulation. 2004 Jan 6;109(1):30-35. doi: 10.1161/01.CIR.0000109482.92774.3A
- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612
- Darbar D, Kannankeril PJ, Donahue BS, et al. Cardiac sodium channel (SCN5 A) variants associated with atrial fibrillation. Circulation. 2008 Apr 15;117(15):1927-1935. doi: 10.1161/CIRCULATIONAHA.107.757955
- Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med. 1997 Mar 27;336(13):905-911. doi: 10.1056/NEJM199703273361302
- Bagnall RD, Weintraub RG, Ingles J, et al. A prospective study of sudden cardiac death among children and young adults. N Engl J Med. 2016 Jun 23;374(25):2441-2452. doi: 10.1056/NEJMoa1510687
- Lahrouchi N, Raju H, Lodder EM, et al. The yield of postmortem genetic testing in sudden death cases with structural findings at autopsy. Eur J Hum Genet. 2020 Jan;28(1):17-22. doi: 10.1038/s41431-019-0500-8
- Campuzano O, Allegue C, Partemi S, Iglesias A, Oliva A, Brugada R. Negative autopsy and sudden cardiac death. Int J Legal Med. 2014 Jul;128(4):599-606. doi: 10.1007/s00414-014-0966-4
- Coll M, Alcalde M, Fernández-Falgueras A, et al. Value of molecular autopsy in suspected sudden cardiac death in the young. J Mol Diagn. 2025 Sep;27(9):859-868. doi: 10.1016/j.jmoldx.2025.05.006
DOI: https://doi.org/10.14797/mdcvj.1827 | Journal eISSN: 1947-6108
Language: English
Page range: 78 - 86
Submitted on: Mar 19, 2026
Accepted on: Jun 23, 2026
Published on: Sep 15, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2026 Ramon Brugada, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.